Role of Hematological Markers in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma Treated With Pembrolizumab. Hagiwara K, Matsuki T, Okada T, Fushimi C, et al. Anticancer Res 2024;44:4057-4072.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Hagiwara K, Matsuki T, Okada T, Fushimi C, et al. Role of Hematological Markers in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma Treated With Pembrolizumab. Anticancer Res 2024;44:4057-4072.
PMID: 39197913